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Cellular/Molecular
Inorganic Polyphosphate Regulates AMPA and NMDA
Receptors and Protects Against Glutamate Excitotoxicity via
Activation of P2Y Receptors
Marta Maiolino,3 Nathanael O’Neill,2 Vincenzo Lariccia,3 Salvatore Amoroso,3 Sergiy Sylantyev,2
Plamena R. Angelova,1,4 and XAndrey Y. Abramov1
1Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, LondonWC1N 3BG, United Kingdom, 2Centre for Clinical Brain
Sciences, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom, 3Department of Biomedical Sciences and Public Health, School of Medicine,
University “Politecnica delle Marche,” 60126 Ancona, Italy, and 4Department of Pathophysiology, I.M. Sechenov First Moscow State Medical University,
119048 Moscow, Russia
Glutamate is one of the most important neurotransmitters in the process of signal transduction in the CNS. Excessive amounts of this
neurotransmitter lead to glutamate excitotoxicity, which is accountable for neuronal death in acute neurological disorders, including
stroke and trauma, and in neurodegenerative diseases. Inorganic polyphosphate (PolyP) plays multiple roles in the mammalian brain,
including function as a calcium-dependent gliotransmittermediating communication between astrocytes, while its role in the regulation
of neuronal activity is unknown. Here we studied the effect of PolyP on glutamate-induced calcium signal in primary rat neurons in both
physiological and pathological conditions.We found that preincubation of primary neurons with PolyP reduced glutamate-induced and
AMPA-induced but not the NMDA-induced calcium signal. However, in rat hippocampal acute slices, PolyP reduced ion flux through
NMDA and AMPA receptors in native neurons. The effect of PolyP on glutamate and specifically on the AMPA receptors was dependent
on the presence of P2Y1 but not of P2X receptor inhibitors and also could be mimicked by P2Y1 agonist 2MeSADP. Preincubation of
cortical neurons with PolyP significantly reduced the initial calcium peak as well as the number of neurons with delayed calcium
deregulation in response to high concentrations of glutamate and resulted in protection of neurons against glutamate-induced cell death.
As a result, activation of P2Y1 receptors by PolyP reduced calcium signal acting through AMPA receptors, thus protecting neurons
against glutamate excitotoxicity by reduction of the calcium overload and restoration of mitochondrial function.
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Introduction
Signal transduction in the CNS is a well balanced process that
includes multiple players and factors. In astrocytes, signals prop-
agate predominantly through calcium signaling, and in neurons
it is mostly a change in plasma membrane potential and calcium
signal (Fellin, 2009; Bazargani and Attwell, 2016). Neurons are
capable of the release ofmultiple and very diverse neurotransmit-
ters and neuromodulators. Astrocytes release gliotransmitters,
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Significance Statement
One of the oldest polymers in the evolution of living matter is the inorganic polyphosphate (PolyP). It is shown to play a role of
gliotransmitter in the brain; however, the role of polyphosphate in neuronal signaling is not clear. Here we demonstrate that
inorganic polyphosphate is able to reduce calcium signaling induced by physiological or high concentrations of glutamate. The
effect ofpolyphosphateonglutamate-inducedcalciumsignal inneurons isdue to the effect of thispolymeron theAMPAreceptors.
The effect of PolyP on glutamate-induced and AMPA-induced calcium signal is dependent on P2Y receptor antagonist. The ability of
PolyP to restrict the glutamate-induced calcium signal lies in the basis of its protection of neurons against glutamate excitotoxicity.
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which can also have an effect on neurons (Gundersen et al.,
2015). One of the major neurotransmitters is glutamate, which
can act as an excitatory transmitter in the vast majority of the
neurons and play a role of a signaling molecule for astrocytes
(Hertz and Zielke, 2004). Synaptically released glutamate acti-
vates ionotropic or metabotropic glutamate receptors, which
change the electrical activity of neurons and trigger the Ca2
signal. Prolonged stimulation of neurons with a high concentra-
tion of glutamate, as seen in many pathologies, leads to excito-
toxicity, and is believed to be one of the major reasons behind
neuronal loss in stroke, epilepsy, and some neurodegenerative
diseases (Olney, 1969; Choi, 1985). Both excitatory and inhibi-
tory types of neurotransmission are mediated in large part by
glutamate and GABA; however, some other neurotransmitters
and neuromodulators, including dopamine and those of the pu-
rinergic system, could modify the glutamate signal (Krnjevic´,
1970; Vaarmann et al., 2013).
One of the oldest polymers in the evolution of the living mat-
ter is the inorganic polyphosphate (PolyP). It plays an essential
role in bacteria, yeast, and protozoa, but is also presented in
relatively high concentration in the mammalian brain, up to 50
M, where it acts as a gliotransmitter (Lorenz et al., 1997; Holm-
stro¨m et al., 2013; Angelova et al., 2014, 2018). As seen by the
relatively small number of publications in this field to date, the
function of this polymer is largely underestimated, especially for
the brain. Potentially, PolyP can play multiple roles in the CNS
(Kumble and Kornberg, 1995; Angelova et al., 2016; Cremers et
al., 2016; Mu¨ller et al., 2017). For example, in astrocytes it is
localized in mitochondria, lysosomes, and vesicular nucleotide
transporter (VNUT)-containing vesicles (Abramov et al., 2007;
Pavlov et al., 2010; Holmstro¨m et al., 2013; Angelova et al., 2018).
PolyP is released from lysosomes or VNUT vesicles by exocytosis,
which leads to the development of calciumwaves (Holmstro¨m et
al., 2013; Angelova et al., 2018). Structurally, PolyP consists of
long chains of only orthophosphate residues, but despite such a
simple composition it is able to activate
P2Y1 receptors, stimulating the activation
of phospholipase C and inducing the re-
lease of Ca2 from the endoplasmic retic-
ulum via the IP3 receptors (Holmstro¨m et
al., 2013; Dinarvand et al., 2014). More-
over, PolyP directly induces calcium sig-
nal in only3%of the neurons, and it has
been found positioned to the synapses
(Holmstro¨m et al., 2013; Stotz et al.,
2014). Furthermore, it has been shown to
modulate the activity of ion channels (i.e.,
TRPM8 channels; Zakharian et al., 2009).
However, PolyP significantly changes
neuronal activity in vivo (Holmstro¨m et
al., 2013), and this effect can be induced
both directly, by the effect of PolyP on
neurons, or indirectly, through the activa-
tion of astrocytes. Here, we study whether
PolyP is as well able to reduce the
glutamate-induced calcium signal and in
particular the signal mediated by AMPA
and NMDA receptors (NMDARs). We
then tested whether the effect of PolyP on
the calcium signal stimulated by gluta-
mate involves the purinergic system. Fi-
nally, we tested the ability of PolyP to
influence the glutamate-induced calcium
signal and effectively protect neurons from the delayed calcium
deregulation (DCD) and consequently from glutamate-induced
cell death.
Materials andMethods
Cell culture.Cocultures of cortical neurons and astrocytes were prepared
from Sprague Dawley rat pups of either sex 2–4 d postpartum (from a
UCL breeding colony) as described previously (Angelova et al., 2019).
Brain cortices were removed into ice-cold HBSS (Ca2, Mg2-free; In-
vitrogen). The tissue was minced and trypsinized (0.1% for 15 min at
37°C), triturated, plated onpoly-D-lysine-coated coverslips, and cultured
in Neurobasal Medium (Thermo Fisher Scientific) supplemented with
B-27 (Thermo Fisher Scientific) and 2 mM L-glutamine. The cultures
weremaintained at 37°C (5%CO2), and themedia changed twice a week.
To avoid the age dependence on theDCD, cells were used after 12–15 d in
vitro in all experiments.
[Ca2]c and [m] imaging. Hippocampal or cortical neurons were
loaded for 30 min at room temperature with 5 M fura-FF AM (Molec-
ular Probes) or 5M fura-2AM(Molecular Probes) and 0.005%Pluronic
acid in an HBSS: 156 NaCl, 3 KCl, 2 MgSO4, 1.25 KH2PO4, 2 CaCl2, 10
glucose, and 10 HEPES, pH adjusted to 7.35. For simultaneousmeasure-
ment of [Ca2]c and mitochondrial membrane potential (m), Rh123
(1 M, Thermo Fisher Scientific) was added into the cultures during the
last 15min of the fura-2 or fura-FF loading period, and the cells were then
washed three to five times before an experiment. Fluorescence measure-
ments were obtained on an epifluorescence inverted Olympus micro-
scope equipped with a 20 fluorite objective. [Ca2]c and m were
monitored in single cells using excitation light provided by a xenon arc
lamp, with the beam passing sequentially through 10 nm bandpass filters
centered at 340, 380, and 490 nm housed in a computer-controlled filter
wheel (Cairn Research). Emitted fluorescence light was reflected through
a 515 nm long-pass filter to a cooled CCD camera (Retiga, QImaging).
The fura-2 or fura-FF data have not been calibrated in terms of [Ca2]c
because of the uncertainty arising from the use of different calibration
techniques. For Fura ratio calculation, we used the maximal value of
fluorescence obtained during glutamate exposure and, as the baseline,
the mean of fluorescence recorded during the time preceding the stimu-
lation. For m measurements, we have normalized the fluorescence
Figure 1. PolyP suppresses the effect of low glutamate concentrations (5M) on neuronal calcium signal. A, Application of 5
M glutamate to cortical neurons induced a rise in [Ca 2]c (fura-2 ratio).B, Pretreatment of 20M S-PolyP significantly reduced
theglutamate-induced calciumsignal.C, Histogramrepresenting theeffect of different lengths of PolyPon theglutamate-induced
calcium signals in cortical neurons as afura-2 ratio between the basal level of [Ca 2]c and themaximal peak after glutamate (5
M) application. *p 0.05, **p 0.001.
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signals between resting level (set to 0) and a maximal signal (which
correspond to full mitochondrial depolarization) generated in response
to the protonophore FCCP (carbonyl cyanide-p-trifluoromethoxyphe-
nylhydrazone; 1 M; set to 100%). Changes in Rh123 fluorescence were
then expressed as the difference between peak values (at 15min) attained
during glutamate stimulation and basal values. All imaging data were
collected and analyzed using iQ3 software from (Andor).
PolyP standards (sodium salt). Short-length PolyP (S-PolyP) 14 orto-
phosphates, medium-length (M-PolyP) 60 ortophosphates, and long-
length PolyP (L-PolyP) 130 ortophosphates were provided by Dr. T.
Shiba (RegeneTiss).
Neuronal toxicity experiment. For toxicity assay, cortical neurons were
sequentially exposed to 20M PolyP for 10min and to 100M glutamate
for a further 30 min. When P2Y and P2X inhibitors were tested, com-
pounds were added 20 min before PolyP exposure. Then, cells were
cultured with freshmedia without polyp and glutamate, and cell viability
was assessed 24 h after treating neurons with 20 M propidium iodide
(PI) and 4.5 M Hoechst 33342 stain (Thermo Fisher Scientific) for 30
min before imaging. The PI is excluded from viable cells and exhibits a
red fluorescence (excitation, 530 nm; emission, 560 nm) following a
loss ofmembrane integrity, while theHoechst 33342 stain labels all nuclei
blue (excitation, 405 nm; emission, 460 nm). This allows subtraction of
the number of dead (red-stained) cells from the total number of cells
counted (blue-stained nuclei). Using phase contrast optics, a bright-field
image allowed the identification of neurons, which are morphologically
different from the flatter glial component and lie in a different focal
plane, above the glial layer. A total number of 100–300 neurons or glial
cells was counted in five to six fields of each coverslip. Each experiment
was repeated three ormore times, using different neuronal preparations.
Electrophysiology. Transverse hippocampal slices (300–400m thick)
were used for in vitro electrophysiological recordings. Slices were pre-
pared from 3- to 5-week-old SpragueDawley rats. Animals were killed by
cervical dislocation after being anesthetized by an overdose of isoflurane
according to theUnited KingdomAnimals (Scientific Procedures) Act of
1986. After decapitation, brains were rapidly removed and dissected, and
whole-brain sagittal slices were prepared with a Leica VT1200S Vi-
bratome in an ice-cold sucrose-based solution containing the following
(in mM): 70 sucrose, 80 NaCl, 2.5 KCl, 7 MgCl2, 0.5 CaCl2, 25 NaHCO3,
1.25 NaH2PO4, and 22 glucose, equilibrated with 95% O2 plus 5% CO2,
at pH 7.35 and 315–330 mOsm. Slices were equilibrated to room tem-
Figure 2. PolyP reduces the number of neurons with DCD induced by high concentration of glutamate. A, Kinetic measurements of the changes in [Ca 2]c (fura-FF ratio) of single neurons in
response to100Mglutamate inprimary cortical cocultures.B–D, Pretreatment (6min)of cortical neuronswith respectively short,medium,and longPolyP reduced [Ca 2]c responses toglutamate
(100M). E, Changes in the percentage of neurons responding to glutamate (100M)-induced DCD after pretreatmentwith different lengths of PolyP. F, Histogram showing the effect of different
length of PolyP on total glutamate-induced calcium increase (fura-FF ratio between basal and maximal amplitude) in cortical neurons.*p 0.05, ***p 0.0001.
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perature and then placed to recover in continuously oxygenated sucrose-
ACSF chamber for at least 1 h before recording. After recovering,
individual slices were transferred into a recording chamber. The perfu-
sion solution contained the following (in mM): 119 NaCl, 2.5 KCl, 1.3
MgSO4, 2.5 CaCl2, 26.2 NaHCO3, 1 NaH2PO4, and 22 glucose and was
continuously gassed with 95%O2 and 5%CO2, at pH 7.35 and 290–298
mOsm. For the whole-cell patch-clamp recordings, we used borosilicate
glass electrodes of 4–6M impedance. Recordings were performedwith
aMulticlamp 700B Amplifier running under pClamp 11x software (Mo-
lecular Devices). The intracellular pipette solution contained the follow-
ing (in mM): 120.5 CsCl, 10 KOH-HEPES, 2 EGTA, 8 NaCl, 5 QX-314
Br	 salt, 2 Mg-ATP, and 0.3 Na-GTP. Voltage-clamp recordings of
NMDARs activity in hippocampal dentate gyrus granule cells (DGCs)
were performed at a holding potential of 30 mV. To isolate the
NMDAR response pharmacologically, we added to the perfusion solu-
tion the following antagonists (in M): picrotoxin 50, GGP-55645 1,
strychnine 1, NBQX 20, and S-MCPG 200. Voltage-clamp recordings of
AMPA receptor (AMPAR) activity in DGCs were performed at a 	70
mV holding potential. To isolate the AMPAR response pharmacologi-
cally, we added to the perfusion solution the following antagonists (in
M): picrotoxin 50, GGP-55645 1, strychnine 1, APV 50, and S-MCPG
200. For both NMDAR and AMPAR recordings, the response amplitude
after polyphosphate application was normalized to that of control re-
cording from the same cell. Synaptic responses were evoked by bipolar
tungsten electrode placed in perforant path and connected to DS2A
constant-voltage stimulator (Digitimer). Electrical stimuli were applied
with a 200 ms time interval once per 15 s.
Statistical and data analysis. Statistical analysis and data analysis were
performed using Origin 9 software (Microcal Software). Statistical anal-
ysis was performed using an unpaired or paired two-tailed Student’s t
test, as indicated. A test for outliers was not conducted on the data.
Results are expressed as themean
 SEM.Differences were considered to
be significantly different at p 0.05.
Results
PolyP decreases glutamate-induced calcium signal
The application of the physiological concentration of glutamate
(5 M) to the primary cortical coculture of neurons and astro-
cytes induced a fast and transient increase in the [Ca2]c of neu-
rons (by 1.57 
 0.04 fura-2 ratio; n  120; Fig. 1A,C).
Stimulation of neurons with S-PolyP (5–15 orthophosphates; 20
M) induced only minor changes in the [Ca2]c of neurons (Fig.
1B). However, the consequent addition of 5M glutamate results
in a significantly lower calcium signal in these neurons compared
with control [fura-2 ratio from 1.56
 0.04 (n 120) to 0.98

0.04 (n  63); p  0.0001; Fig. 1B,C]. The ability of PolyP to
reduce glutamate-induced calcium signal was dependent on the
length of polymer: it was less effective with elongation of the
chain (Fig. 1C).
High and toxic concentrations of glutamate induce initial cal-
cium influx followed by DCD, which triggers excitotoxicity (Fig.
2A). Preincubation of neurons with 20 M S-PolyP (p 0.0157;
Fig. 2B) and M-PolyP (p  0.0250; Fig. 2C) both significantly
reduced the number of cells with delayed calcium deregulation.
Importantly, S-PolyP wasmore effective in the overall protection
of the neurons against the occurrence of DCD compared with
M-PolyP and L-PolyP (Fig. 2E), but, interestingly, all types of
PolyP significantly decreased the amplitude of glutamate-
induced (100 M) calcium signal (from 0.64
 0.03, n 178 in
Figure 3. PolyP mitigates the glutamate-induced mitochondrial membrane depolarization. A, Application of toxic (100M) concentrations of glutamate induced a decrease inm (repre-
sentedasan increase inRhodamine123 signal,maximaldepolarizationafter 1MFCCPwas takenas100%).B, Pretreatmentof cortical neuronswithS-PolyP reduced theeffect of high concentration
of glutamate onmitochondrialmembranepotential.C, Average traces from single representative experiments showing kinetic changes inmof control andPolyP-pretreatedneurons in response
to 100M glutamate. D, Summary of the effect of S-PolyP on the glutamate-induced mitochondrial depolarization in cortical neurons. *p 0.05.
Maiolino et al. • Regulation of Glutamate Signal in Neurons by Inorganic Polyphosphate J. Neurosci., July 31, 2019 • 39(31):6038–6048 • 6041
control to the following: 0.32 
 0.04, n  64, p  0.0001 for
S-PolyP; 0.45 
 0.03, n  146, p  0.0001 for M-PolyP; and
0.45 
 0.03, n  97, p  0.0001 for L-PolyP, respectively; Fig.
2F). Thus, both S-PolyP and M-PolyP are more effective in sup-
pressing the glutamate-induced calcium signal that results in
protection of the neurons against excitotoxic DCD compared
with L-PolyP.
PolyP reduces glutamate-induced
mitochondrial depolarization
Glutamate-inducedDCD is associated with profoundmitochon-
drial depolarization (Vergun et al., 1999; Abramov and Duchen,
2008). In our experiments, the exposure of neurons to 100 M
glutamate induced simultaneous DCD and mitochondrial depo-
larization (the Rh123 signal rose by 38 
 12% in 7 min after
glutamate addition, n 81; Fig. 3A,D). Preincubation of cortical
neurons with 20M S-PolyP did not change basal mitochondrial
potential but significantly reduced the effect of high glutamate
exposure on m (Fig. 3B–D). Thus, Rh123 fluorescence rose
only to 17
 5% (n 55, p 0.0279), which correlates with the
decrease of the number of cells with DCD in cultures treated with
S-PolyP.
PolyP reduces glutamate-stimulated calcium signal via
P2Y receptors
PolyP can stimulate P2Y receptors and induce the release of
vesicles with transmitters that potentially can have an effect on
glutamate signal (Holmstro¨m et al., 2013; Angelova et al.,
Figure 4. Modulation of the glutamate-induced calcium signal by S-PolyP is P2Y receptor mediated. A–E, Kinetic measurement of the changes in [Ca 2]c from single neurons in response to 5
M glutamate in cortical cultures with (B–E) andwithout (A) S-PolyP, in the presence of P2 receptors antagonists 20M suramin (C), 20M TNP-ATP (D), and 20M PPADS (E). F, Summary of the
effects of P2 receptor antagonists on the S-PolyP action on glutamate-induced calcium signal. *p 0.05.
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2018). To assess the potential effect of the purinergic system in
the PolyP-induced reduction of glutamate response, we used in-
hibitors of P2Y and P2X receptors, suramin, and TNP (2,4,6-
trinitrophenol)-ATP, respectively. In agreement with the data
presented in Figure 1, short PolyP induced a significant reduction
of the glutamate-induced calcium signal compared with un-
treated cells (from 1.57
 0.05, n 120 in control to 0.98
 0.05
with S-PolyP, n 91; p 0.0001; Fig. 4A,B,F). Preincubation of
the cortical coculture with 20M suramin significantly mitigated
the effects of S-PolyP on calcium signal induced by 5 M gluta-
mate [from in 0.98
 0.05 with S-PolyP (n 91) to 1.27
 0.07
(n  63); p  0.0002; Fig. 4C,F]. Importantly, preincubation of
the cortical coculture with the more specific inhibitor for P2X
receptors (20 M TNP-ATP) had no significant effect on the
action of PolyP on the glutamate-induced rise in [Ca2]c of cor-
tical neurons (n 76; Fig. 4D,F). Another inhibitor of P2 (more
specific for P2X) receptors, PPADS (pyridoxalphosphate-6-
azophenyl-2,4-disulfonic acid tetrasodium salt), also had no
effect on the ability of PolyP to reduce the calcium signal under
application of 5 M glutamate (n 44; Fig. 4E,F).
Stimulation of P2 receptors by PolyP reduce the number of
cells with DCD
The ability of PolyP to reduceDCD in neurons under exposure of
the 100 M glutamate was also dependent on the presence of the
inhibitor of the P2Y receptor suramin (n  48, p  0.0007; Fig.
Figure 5. Effect of PolyP on [Ca 2]c rise in response to toxic concentration of glutamate (100M) in the presence of P2 receptor antagonists. A, B, One hundredmicromolar glutamate induced
profound elevation of [Ca 2]c in primary cortical neurons (A), which could be reduced by pretreatment of the cells with 20M PolyP (B). C–E, Preincubation of primary cortical coculture with P2
receptors blockers 20M suramin (C), 20M TNP-ATP (D), and 20M PPADS (E) modified the effect of S-PolyP on glutamate-induced calcium signal. F, Summary of the effects of P2 antagonists
on the reduction of glutamate-induced calcium signal by PolyP (fura-FF ratio between basal calcium level and maximal calcium amplitude after application of 100M glutamate). *p 0.05,
***p 0.0001.
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5C,F) and PPADS (n  32, p  0.0208;
Fig. 5E,F), but not TNP-ATP (n  36,
p  0.0676; Fig. 5D,F). Thus, PolyP acts
more likely through P2Y receptors to re-
duce calcium responses to physiological
(5 M) and excitotoxic (100 M) concen-
trations of glutamate.
PolyP stimulates P2Y1 receptor and
reduces calcium signal through
AMPA receptors
To identify which type of glutamate re-
ceptor is affected by PolyP, we used the
application of receptor agonists AMPA
andNMDA to fura-2-loaded cortical neu-
rons. The addition of 20 M NMDA in-
duced a rise in the [Ca2]c of cortical
neurons (n 88; Fig. 6A, J). The exposure
of the neurons to 20 M short PolyP did
not significantly change the amplitude or
the shape of the calcium signal in response
to NMDA (n  76; Fig. 6B, J). However,
short PolyP significantly reduced AMPA-
induced calcium signal in neurons com-
pared with control cells [from 2.3
 0.142
(n  208) to 0.3045 
 0.0469 (n  161);
p  0.0001; Fig. 6C,D, J]. Importantly,
suramin suppressed the action of S-PolyP
on AMPA-induced calcium signal in the
same way as it did for glutamate [from
0.3045 
 0.0469 (n  161) to 2.459 

0.1806 (n  132); p  0.0004; Fig. 6E, J].
However, considering that none of the
following P2 receptor antagonists used is
purely selective for P2X or P2Y (suramin,
PPADS, or TNP-ATP), we used a selective
antagonist for the P2Y1 receptorMRS2179
(2-deoxy-N6-methyladenosine 3,5-bisp-
hosphate tetrasodium salt). Preincuba-
tion of primary cortical neurons with 50
M MRS2179 completely prevented the
effect of short PolyP on AMPA-induced
calcium signal [from 0.3045 
 0.0469
(n  161) to 2.409 
 0.1765 (n  157);
p  0.0016; Fig. 6F, J]. Thus, PolyP acti-
vates P2Y1 receptors, which reduce cal-
cium signal through AMPA receptors in
response to AMPA or glutamate. Applica-
tion of another classical agonist of P2 re-
ceptors, ATP, at 100M, induced a typical
calcium signal as expected only in astro-
cytes (data not shown), but not in
neurons (Fig. 6G). Interestingly, pre-
stimulation of neurons with 100 M ATP
did not reach statistical significance in the
Figure 6. Effects of PolyP on the AMPA- and NMDA-induced calcium signals. A, The 20M NMDA-induced calcium signal in
cortical neurons (fura-2 ratio).B, Preapplication of short PolyP (20M) had no significant effect on NMDA-induced increase in the
fura-2 ratio. C, D, Effect of AMPA (20M) on [Ca 2]c of cortical neurons (C) can be reduced by pretreatment of cells with 20M
S-PolyP (D). E, F, J, P2 antagonist suramin (20M; E, J ) or P2Y1 blocker MRS2179 (50M; F ) completely abolished the effect of
S-PolyP on the AMPA-induced calcium signal. G, H, Agonist of P2 receptor ATP-induced calcium rise in astrocytes did change
neuronal [Ca 2]c in response to 20 M AMPA significantly when applied at 10 M (H ), but not at 100 M (G) concentration.
4
I, A more specific agonist of the P2Y1, P2Y12, and P2Y13 re-
ceptor 2MeSADP, at 1M, mimicked the effect of S-PolyP on
the AMPA receptors. J, Summary of the effects of P2 agonists
and antagonists on the S-PolyP effect on the AMPA-induced
calcium signal. ***p 0.0001.
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change of AMPA-induced calcium signal in these neurons (n 
82; p 0.0977; Fig. 6G,J). However, when reduced to a concen-
tration of 10 M ATP induced a primary response in cortical
neurons and significantly reduced the AMPA-evoked calcium
signal from 2.3 
 0.142 (n  208) to 0.7 
 0.055 (n  54; p 
0.0001; Fig. 6H, J). Additionally, the application of another P2Y
agonist 2MeSADP (2-methylthio-adenosine-5-diphosphate; 1
M; a P2Y1, P2Y12, and P2Y13 receptor, moderately potent aa
P2Y11 receptors), was able to reduce the AMPA-induced calcium
signal in neurons similar to the level of reduction by 20M short-
chain PolyP (0.3045 
 0.0469, n  161, for AMPAS PolyP;
compared with 0.796 
 0.095, n  77, for AMPA2MeSADP;
p 0.0001; Fig. 6 I, J).
PolyP downregulates electrophysiological neural response in
living tissue
Considering the role that has been given to the P2Y receptors in
the literature for activation of electrical activity of glutamate
receptors and to test the effects of PolyP in a system where inter-
cellular interaction is more pronounced, we studied the effect of
stimulation with PolyP in ex vivo hippocampal slices. To test
whether PolyP affects electrical charge transfer through NMDARs in
native DGCs, we performed electrophysiological recording of
pharmacologically isolated NMDAR and AMPAR response
evoked by electrical stimulation (Fig. 7A,B). We found that both
long-chain and short-chain 20 M PolyP, when added to perfu-
sion solution, decreased the NMDAR response amplitude signif-
icantly (L-PolyP: to 0.66
 0.09 of control value; n 5; p 0.05,
paired Student’s t test; S-PolyP: to 0.67
 0.08 of control; n 8;
p 0.01, paired Student’s t test). However, neither L-PolyP nor
S-PolyP significantly affected the paired-pulse ratio (PPR)
of paired responses (for L-PolyP: 0.97 
 0.07; n  5; p  0.05,
paired Student’s t test; for S-PolyP: 0.94
 0.38; n 8; p 0.05,
paired Student’s t test.
Similarly, PolyP species affected the response amplitude, but
not the PPR, of AMPARs (Fig. 7C,D). Both the long-chain and
short-chain 20 M PolyP downregulated the amplitude of phar-
macologically isolated AMPAR response to 0.72 
 0.068 and
0.58 
 0.092 of control, respectively (n  8; in both cases, p 
0.01, paired Student’s t test). The PPR of the AMPAR response
was calculated to be 1.12 
 0.11 of control with L-PolyP and
0.97 
 0.083 of control with S-PolyP (n  8; p  0.05 for both
cases, paired Student’s t test).
Figure 7. Polyphosphate suppresses the glutamate receptor synaptic response. A, Representative traces illustrating the impact of 20M PolyP on the response generated by isolated NMDARs
from DGCs from the hippocampus. Top, L-PolyP (L-PP); bottom, S-PolyP (S-PP).B, Summary of the effects depicted in A: first response amplitudes and PPR. C, Representative traces illustrating the
impact of 20M PolyP on the response generated by isolated AMPARs in DGCs. Top, L-PolyP (L-PP); bottom, S-PolyP (S-PP). D, Statistical summary of the effects of PolyP in C on the first response
amplitudes and PPR. Data were normalized to values generated under control; asterisks denote significance of difference from unity. *p 0.05, **p 0.01.
Maiolino et al. • Regulation of Glutamate Signal in Neurons by Inorganic Polyphosphate J. Neurosci., July 31, 2019 • 39(31):6038–6048 • 6045
PolyP protects neurons against glutamate excitotoxicity via
P2Y receptors
The application of 100 M glutamate to cortical coculture neu-
rons and astrocytes induced significant cell death measured 24 h
after stimulation (36.6
 5.4, n 250; Fig. 8B). High concentra-
tions of long PolyP also can be toxic for neurons (Angelova et al.,
2016). However, preincubation (20 M, 10 min) of the cortical
cocultures with long, medium, or short PolyP significantly de-
creased the number of glutamate-induced dead cells (to
10.47
 0.95, 12.54
 1.75, and 12.62
 2.33, respectively, for
both; n 250; p 0.0001; Fig. 8A,B). Importantly, the inhib-
itor of P2Y receptors suramin (20 M added 20 min before
S-PolyP and glutamate) significantly reduced the protective
effect of 20 M short PolyP against glutamate-induced excito-
toxicity (from 26.48
 2.38 to 10.18
 0.89, for both; n 250;
p  0.0001; Fig. 8C), while a more selective inhibitor of P2X
receptor TNP-ATP (20 M, 20 min before PolyP and gluta-
mate) had no effect on neuronal viability. This strongly sug-
gests that PolyP protects neurons against glutamate-induced
toxicity via stimulation of P2Y receptors.
Discussion
In the present study, we found that PolyP is able to reduce the
physiological calcium signal induced by glutamate. This effect
was dependent on the length of the polymer, and activity was
reduced with elongation of the polyphosphate chain. The ability
of PolyP to reduce Ca2 influx through glutamate receptors is
more likely to be a basis for significant reduction of the number of
neurons with DCD underexposure of the cells with a toxic con-
centration of glutamate (100 M). DCD is induced by multiple
factors (Vergun et al., 1999; Khodorov, 2004; Abramov and
Duchen, 2010) but is initiated by massive ion flux through
glutamate receptors. Reduction of the calcium influx or acti-
vation of Ca2-ATPases protects neurons against DCD in-
duced by high concentrations of glutamate in the same way as
PolyP (Suwanjang et al., 2013; Vaarmann et al., 2013). Al-
though PolyP is shown to play an important role in mitochon-
dria (Abramov et al., 2007; Pavlov et al., 2010), and in our
experiments PolyP significantly reduced glutamate-induced
depolarization (Fig. 4), the protective effect of PolyP is less
likely due to the direct effect on mitochondria. The effect of
this polymer on m under glutamate exposure is more likely
due to the reduction of [Ca2]c that leads to lower calcium
uptake into mitochondria. Interestingly, the inhibition or se-
questration of mitochondrial calcium uptake bymitochondria
leads to protection against glutamate-induced depolarization
(Abramov and Duchen, 2008; Angelova et al., 2019).
Figure 8. PolyP protects neurons against glutamate-induced cell death. A, Representative images depicting the effect of PolyP of different length on cell death induced by 100M glutamate
using PI fluorescence. B, Histogram represents the effect of different lengths of PolyP on the glutamate-induced cell death in cortical neurons. C, Histogram summarizing the effect of PolyP on
glutamate-induced toxicity in the presence of P2 receptor antagonists. The number of dead cells was countedwith respect to the total number of cells identified by staining the nuclei with Hoechst
33342 stain. The percentage of death cells shown in the histogramwas calculated as the sumof averagenumber of deadneurons obtained for each field of view. Each experimentwas repeated three
or more times using three or more different neuronal preparations. ***p 0.0001.
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Most of the effects that we observed here (reduction of the
calcium signal upon stimulation with low or high concentrations
of glutamate by PolyP and protection of the cells against gluta-
mate toxicity) were dependent of the presence of P2Y (but not
P2X) antagonist suramin. Previously, we and others have shown
that PolyP activates calcium signal in astrocytes (and in 3% neu-
rons) via stimulation of P2Y1 receptor (Holmstro¨m et al., 2013;
Dinarvand et al., 2014). Purinergic receptors (P2X and P2Y) can
be activated by purines (Burnstock, 2013) and induced calcium
signal in astrocytes, that depends on the activation of phospho-
lipase C (Domijan et al., 2014). Activation of both ionotropic
(P2X) and metabotropic (P2Y) receptors suppresses AMPA and
NMDA and protects against glutamate excitotoxicity (Ortega et
al., 2011; Pougnet et al., 2016). PolyP suppresses glutamate-
induced calcium signal and glutamate toxicity via P2Y1, which
can be proven by experiments with the highly selective inhibitor
MRS2179 and less likely through P2X due to weaker effects of
TNP-ATP and PPADS in our experiments.
Clear downregulation of NMDA receptor response amplitude
without significant changes in paired-pulse ratio suggests the
suppression of NMDA receptor conductance due to postsynaptic
mechanisms (i.e., impact on biochemical regulatory networks)
rather than presynaptic mechanisms (i.e., modulation of gluta-
mate release from synaptic bouton).
The Absence of significant PolyP-generated suppression of
NMDA-induced Ca2waves (Fig. 7B) and the presence of such a
suppression of NMDAR electrophysiological response (Fig.
7A,B) looks to be, to some extent, counterintuitive. However,
this apparent discrepancy has two potential explanations. First,
NMDA-induced Ca2 elevation may not be only due to Ca2
transport through NMDA receptor channels; Ca2-induced
Ca2 release from endoplasmic reticulum in response to NMDA
application, which has long been established for DGCs (Lazare-
wicz et al., 1998), provides a good alternative source. Hence, a
Ca2 wave after glutamate receptor activation may be generated
mostly by Ca2 release from endoplasmic reticulum, whereas, to
start such awave,NMDARs at the cytoplasmicmembrane should
provide just an small initial amount of Ca2, which works as a
trigger; therefore, the reduction of Ca2 ion transfer through
NMDARs by PolyP leaves enough Ca2 to initiate release from
endoplasmic reticulum, and thus does not cause a significant
impact on the overall Ca2 rise in cytoplasm.
Second, the permeability of NMDARs to Ca2 depends on
NMDAR subunit composition (Evans et al., 2012). Therefore,
PolyPmay suppress selectivelyNMDARs of subunit composition
with low permeability to Ca2: this would reduce the overall
charge transfer (Fig. 6), but not the overall Ca2 influx (Fig. 6).
On other side, PolyP can directly act on P2Y1 receptors in
neurons producing (or not producing) a much smaller calcium
signal due to much smaller calcium ER pool compared with as-
trocytes. This effect results in suppression of glutamate receptors.
However, we cannot exclude the fact that PolyP induces the acti-
vation of astrocytic P2Y1 receptors (Holmstro¨m et al., 2013) and
stimulates the release of neuromodulators which in turn reduces
the conductance of glutamate receptors for Ca2, one example of
which could be underlying neuron–glia interaction (Angelova
and Abramov, 2014).
Despite the fact that the P2 agonist ATP was shown to be able
to decrease the conductance of glutamate receptors (Ortega et al.,
2011; Pougnet et al., 2016), in our experiments 100 M ATP had
no effect on AMPA-induced calcium signal (Fig. 6G). This could
possibly be explained by the higher selectivity of PolyP to P2Y1
receptor compared with 100 M ATP, which is possibly more
selective to other types of P2 receptors. When we tested a lower
concentration, 10 M ATP, we obtained a similar effect to those
of short PolyP. Importantly, it also can be proven with the P2Y1-
specific agonist 2MeSADP.
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